Introduction
Chimeric Antigen Receptor (CAR) T-cell therapy has already transformed the landscape of cancer treatment. Now, the 4th generation CAR T-cell therapy, augmented with interleukin-15 (IL-15...
car-t-for-solid-tumors
GBMThe glioblastoma multiforme (GBM) is considered the most aggressive and lethal type of brain tumor. Despite treatments that include surgery, radiation, and chemotherapy, it has an unfavorable progn...
car-t-for-solid-tumors
Pancreatic cancer
Pancreatic cancer, also referred to as the "king of cancers," is a highly deadly malignant tumor, with a survival rate of fewer than 10% over a 5-year period. As a result of inadequ...
car-t-for-solid-tumors
Introduction
Immunotherapy has become a groundbreaking method in cancer treatment, especially for advanced-stage cancer treatments that have demonstrated minimal effectiveness with standard m...
car-t-for-solid-tumors
In March 2024, a news release said that A2B530 (A2 Biotherapeutics), a CAR T-cell therapy, had been given Orphan Drug Designation to treat colorectal cancer that expresses carcinoembryonic antigen (C...
car-t-for-solid-tumors